Abstract

The Deciphering the Mechanisms of Developmental Disorders programme has analysed the morphological and molecular phenotypes of embryonic and perinatal lethal mouse mutant lines in order to investigate the causes of embryonic lethality. Here we show that individual whole-embryo RNA-seq of 73 mouse mutant lines (>1000 transcriptomes) identifies transcriptional events underlying embryonic lethality and associates previously uncharacterised genes with specific pathways and tissues. For example, our data suggest that Hmgxb3 is involved in DNA-damage repair and cell-cycle regulation. Further, we separate embryonic delay signatures from mutant line-specific transcriptional changes by developing a baseline mRNA expression catalogue of wild-type mice during early embryogenesis (4–36 somites). Analysis of transcription outside coding sequence identifies deregulation of repetitive elements in Morc2a mutants and a gene involved in gene-specific splicing. Collectively, this work provides a large scale resource to further our understanding of early embryonic developmental disorders.

Details

Title
Common and distinct transcriptional signatures of mammalian embryonic lethality
Author
Collins, John E 1 ; White, Richard J 2   VIAFID ORCID Logo  ; Staudt, Nicole 1 ; Sealy, Ian M 2   VIAFID ORCID Logo  ; Packham, Ian 1 ; Wali, Neha 1 ; Tudor, Catherine 1   VIAFID ORCID Logo  ; Mazzeo, Cecilia 1 ; Green, Angela 1 ; Siragher, Emma 1 ; Ryder, Edward 1 ; White, Jacqueline K 3 ; Papatheodoru, Irene 4   VIAFID ORCID Logo  ; Tang, Amy 4 ; Füllgrabe, Anja 4   VIAFID ORCID Logo  ; Billis, Konstantinos 4   VIAFID ORCID Logo  ; Geyer, Stefan H 5 ; Weninger, Wolfgang J 5 ; Galli, Antonella 1 ; Hemberger, Myriam 6   VIAFID ORCID Logo  ; Stemple, Derek L 7   VIAFID ORCID Logo  ; Robertson, Elizabeth 8   VIAFID ORCID Logo  ; Smith, James C 9   VIAFID ORCID Logo  ; Mohun, Timothy 9 ; Adams, David J 1 ; Busch-Nentwich, Elisabeth M 2   VIAFID ORCID Logo 

 Wellcome Sanger Institute, Wellcome Genome Campus, Cambridge, UK 
 Wellcome Sanger Institute, Wellcome Genome Campus, Cambridge, UK; Cambridge Institute of Therapeutic Immunology & Infectious Disease (CITIID), Jeffrey Cheah Biomedical Centre, University of Cambridge, Cambridge, UK 
 Wellcome Sanger Institute, Wellcome Genome Campus, Cambridge, UK; The Jackson Laboratory, Bar Harbor, ME, USA 
 European Molecular Biology Laboratory, European Bioinformatics Institute, Wellcome Genome Campus, Cambridge, UK 
 Division of Anatomy, MIC, Medical University of Vienna, Wien, Austria 
 The Babraham Institute, Babraham Research Campus, Cambridge, UK; Centre for Trophoblast Research, University of Cambridge, Cambridge, UK; Departments of Biochemistry & Molecular Biology and Medical Genetics, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada 
 Wellcome Sanger Institute, Wellcome Genome Campus, Cambridge, UK; Camena Bioscience, The Science Village, Cambridge, UK 
 Sir William Dunn School of Pathology, University of Oxford, Oxford, UK 
 The Francis Crick Institute, London, UK 
Pages
1-16
Publication year
2019
Publication date
Jun 2019
Publisher
Nature Publishing Group
e-ISSN
20411723
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2247652536
Copyright
© 2019. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.